Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of blood sugar

The 'Cardio Risk Check' or cardiovascular risk test in the context of blood sugar is a screening tool typically based on biomarkers like fasting glucose, HbA1c, or genetic variants (e.g., ADIPOQ). The evidence for such combined tests is mixed: fasting glucose and HbA1c are well-validated risk markers for diabetes and cardiovascular events (human-moderate evidence). Genetic components like ADIPOQ have mostly mechanistic evidence—they show biological links but lack clinically relevant effect sizes for individuals. A normal blood sugar level does not rule out elevated cardiovascular risk, as many other factors (lipids, blood pressure, lifestyle) are critical. The test can provide orientation but does not replace medical diagnosis. Caution against overinterpretation: a single value says nothing about long-term trends or subclinical disorders. If results are abnormal, consult a physician. Evidence: mixed—partly human-moderate (blood sugar), partly mechanistic (genetics).